HHSE FORM 10 FILING

New Post Public Reply Private Reply Replies (0) Message Board
speckulater
399
HHSE FORM 10 FILING INEVITABLE!











As of the Date of This Filing, Issuer Hannover House, Inc. (Symbol OTC: HHSE) has Not Yet Registered Its Securities. The Company’s Stock Shares are Currently Being Traded on the OTC Markets Pinksheets Exchange. Issuer is in The Process of Completing the Filing of a Form 10 Registration Imminently, After Which Time, the Company’s Shares Will Become Registered With the Securities and Exchange Commission.

https://www.sec.gov/Archives/edgar/data/10696...orm8-k.htm

The Form 10 Registration Statement Automatically Becomes Effective Sixty Days Post-Filing.
https://www.investopedia.com/terms/s/sec-form-10.asp



SUMMARY HHSE (3) 8-K's + 425 FILINGS. 4 of Them Here, 5 All Together in Month on SEC. I N E V I T A B L E




MINUTES OF THE BOARD OF DIRECTOR’S MEETING - (OTC: HHSE) – Thursday, Dec. 3, 2020
A Special Meeting of the Board of Directors of Hannover House, Inc. Was Held on Thursday, December 3, 2020 Telephonically at 9:30-am CST. The Purpose of This Meeting Was to Address Certain Issues and Disclosures Concerning the Company’s Plan to Open Satellite Offices in New York City and Los Angeles For the MyFlix Venture – As Well as the Engagement of Required Support Staff for Those Locations and the Home Office Location in Arkansas.
A) 1 Business Discussion
B) 2 Detailed Graphs + Tables

https://www.sec.gov/Archives/edgar/data/10696...08/ex1.htm




MINUTES OF THE BOARD OF DIRECTOR’S MEETING (OTC: HHSE) – Friday, Nov. 20, 2020
A Special Meeting of the Board of Directors of Hannover House, Inc. Was Held on Friday, November 20, 2020 Telephonically at 9:30-am CST. The Purpose of This Meeting Was to Address Certain Issues and Disclosures Concerning a Proposed Registration Offering of the Company’s Stock as a Financing Means to Launch and Operate the Company’s MYFLIX Streaming Service. The Following Items Describe the Issues Addressed, and Where Indicated, the Actions Taken By the Board.
A) 4 Business Discussions
B) 4 Deatailed MYFLIX Tables + Analysis

https://www.sec.gov/Archives/edgar/data/10696...44/ex1.htm




MINUTES OF THE BOARD OF DIRECTOR’S MEETING(OTC: HHSE) – Tuesday, Nov. 10, 2020
A Special Meeting of The Board of Directors of Hannover House, Inc. Was Held on Tuesday, November 10, 2020 Telephonically at 9:30-am CST. The Purpose of This Meeting Was to Address Certain Issues and Disclosures Which are Required Prior to the Filing of Either a Form 10-12(g) Registration, or the Companion S1 Stock Registration Offering That the Company Intends to Pursue. The Following Items Describe the Issues Addressed, and Where Indicated, the Actions Taken By the Board.
A) 4 Business Discussions

https://www.sec.gov/Archives/edgar/data/10696...0/ex-1.htm




MINUTES OF THE BOARD OF DIRECTOR’S MEETING (OTC: HHSE) – Tuesday, Nov. 10, 2020
A Special Meeting of the Board of Directors of Hannover House, Inc. Was Held on Tuesday, November 10, 2020 Telephonically at 9:30-am CST. The Purpose of This Meeting Was to Address Certain Issues and Disclosures Which are Required Prior to the Filing of Either a Form 10-12(g) Registration, or the Companion S1 Stock Registration Offering That the Company Intends to Pursue. The Following Items Describe the Issues Addressed, and Where Indicated, the Actions Taken By the Board.
A) 4 Business Discussions

https://www.sec.gov/Archives/edgar/data/10696...1/ex-1.htm




HHSE EDGAR SEARCH RESULTS:

https://www.sec.gov/cgi-bin/browse-edgar?CIK=...er=exclude

https://myflix.com/




Myflix-Image.jpg


Hannover House Inc. (HHSE) Stock Research Links

HHSE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lumexa Imaging's Investor Conference Push: Any Real Substance?

Updated Category News Views 132

Lumexa Imaging just dropped a line on Feb 17, 2026, about their upcoming investor conference gigs. Sure, they're strutting into multiple events—Raymond James in Orlando, Leerink Partners in Miami, and Barclays back-to-back days after that. But here’s the kicker: are these talks really worth the buzz? In a space where outpatient imaging claims to be kingpin, you’ve...

Continue Reading
Current Landscape of US Stock Futures Amid Rate Cuts

Updated Category News Views 173

Insights on the Current Stability of U.S. Stock Futures During Asian trading hours, U.S. stock index futures have held steady. Investors are hoping for interest rate cuts as the Federal Reserve's next meeting approaches. This meeting is expected to reveal a significant easing cycle that many in the market are eagerly anticipating. Even with strong reports on consumer and...

Continue Reading
Wispr Flow Revolutionizes Voice Dictation Across Platforms

Updated Category News Views 469

Wispr Flow Expands Its Reach in Voice Dictation Technology In a world where speed and efficiency are paramount, Wispr, known as The Voice Interface Company, is revolutionizing the way we interact with technology. With the recent launch of Wispr Flow for Windows, this innovative voice productivity tool is now accessible to users across both Mac and Windows platforms,...

Continue Reading
MintMiner: Your Ultimate Gateway to Cloud Mining Success

Updated Category News Views 197

Unlocking the Future of Cloud Mining with MintMiner In today's uncertain financial landscape, MintMiner presents an innovative solution for anyone looking to tap into the world of digital assets. As global financial systems face challenges, MintMiner offers a unique platform that makes cloud mining accessible, straightforward, and profitable. Understanding Cloud Mining...

Continue Reading
GT Biopharma's Strategic Move: Withdrawal of S-1 Registration

Updated Category News Views 100

GT Biopharma's Strategic Withdrawal of Form S-1 Registration GT Biopharma, Inc. (NASDAQ: GTBP) recently made headlines with its request for withdrawal of a Form S-1 registration statement. This decision marks a crucial moment for the company, based in San Francisco, known for its innovative approach in the immuno-oncology sector. GT Biopharma focuses on the development of...

Continue Reading